chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Electrophoresis protein, Fatigue, Feeling abnormal, Hemiparesis, Hypergammaglobulinaemia
Clinical narrative: received pfizer covid vaccines 3/29/2021 and 4/19/2021  as of 10 Dec 2021 Admission summary in 10/ 2021- This previously healthy young man with a history of sensorineural hearing loss approximately 10 years ago first developed some arthralgia following coronavirus 19 vaccination in April 2021 however he and his father report that the symptoms resolved and he returned to normal health before starting to feel poor again in the summer 2021.  He has developed intermittent myalgia and arthralgia and has been experiencing fevers.  He did develop fatigue and has been coughing for weeks.  He was admitted on 10/15 with left hemiparesis and found to have a subacute right lacunar infarct of unstated location and narrowing of bilateral external carotid arteries on CT. On 10/17, he developed right hemiparesis and acute dysphagia and found to have a right lateral medullar infarct. He was transferred another medical facility on 10/17. Rheumatology was consulted for evaluation of a rheumatologic process contributing to presentation in setting of reported ANA positive serology.    He does have unexplained fevers, inflammatory "arthritis", dry eyes (positive Schirmer's test on R eye, negative on L eye), dry mouth, neurologic symptoms (stroke), cytopenias, hypergammaglobulinemia, elevated Immunoglobulin level, positive ANA, weakly positive anti-SSA which could be explained by Sjogren's symptoms. People with seronegative (weakly positive in his case) Sjogren's tend to have neurological manifestations.    Received IV cyclophosphamide 500 mg/m2 (900 mg) (first dose on 11/6/2021), IV methylprednislone 500 mg bid x 6 doses. Tapered to equivalent of prednisone 1 mg/kg, Plaquenil 300 mg daily (started on 11/5/21)    Laboratory studies Abnormal - anti-SSA (2.5), ANA 1:640 homogeneous, SPEP consistent with chronic inflammation (hypoalbuminemia, hypergammaglobinemia), anti-smooth muscle, MOG antibody, elevated interleukin 2 receptor, elevated ESR, elevated CRP.   Normal/Negative - antiMPO/PR3, RF, anti-Smith, anti-SSB, anti-Scl70, anti-centromere, C3/C4, anti-CCP, anti-beta 2 glycoprotein 1 Ab, anti-cardiolipin Ab, urine studies, anti-ds-DNA, serum immunofixation, anti-mitochondrial aby, DRVVT, cryoglobulin, Hex lupus anticoagulant Negative NMO in CSF, TB   Pathology: Lip biopsy showed mild focal periductal chronic inflammation with focus score<1 (focus score 0.44).    INTERVAL HISTORY:  He he has noticed improvement after he was discharged.  He is able to walk at home without problem but he still uses walker whenever he goes out.  He denies any new neurologic symptoms. He is currently on prednisone 30 mg daily. He monitors his blood pressure every day and taking beta-blocker for it.  Beta-blocker is managed by primary doctor. His dry eyes and dry mouth do not really bother him.  He has been drinking a lot of fluid for the dry mouth.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoalbuminaemia, Immunoglobulins increased, Immunology test normal, Inflammation, Interleukin-2 receptor increased
Clinical narrative: received pfizer covid vaccines 3/29/2021 and 4/19/2021  as of 10 Dec 2021 Admission summary in 10/ 2021- This previously healthy young man with a history of sensorineural hearing loss approximately 10 years ago first developed some arthralgia following coronavirus 19 vaccination in April 2021 however he and his father report that the symptoms resolved and he returned to normal health before starting to feel poor again in the summer 2021.  He has developed intermittent myalgia and arthralgia and has been experiencing fevers.  He did develop fatigue and has been coughing for weeks.  He was admitted on 10/15 with left hemiparesis and found to have a subacute right lacunar infarct of unstated location and narrowing of bilateral external carotid arteries on CT. On 10/17, he developed right hemiparesis and acute dysphagia and found to have a right lateral medullar infarct. He was transferred another medical facility on 10/17. Rheumatology was consulted for evaluation of a rheumatologic process contributing to presentation in setting of reported ANA positive serology.    He does have unexplained fevers, inflammatory "arthritis", dry eyes (positive Schirmer's test on R eye, negative on L eye), dry mouth, neurologic symptoms (stroke), cytopenias, hypergammaglobulinemia, elevated Immunoglobulin level, positive ANA, weakly positive anti-SSA which could be explained by Sjogren's symptoms. People with seronegative (weakly positive in his case) Sjogren's tend to have neurological manifestations.    Received IV cyclophosphamide 500 mg/m2 (900 mg) (first dose on 11/6/2021), IV methylprednislone 500 mg bid x 6 doses. Tapered to equivalent of prednisone 1 mg/kg, Plaquenil 300 mg daily (started on 11/5/21)    Laboratory studies Abnormal - anti-SSA (2.5), ANA 1:640 homogeneous, SPEP consistent with chronic inflammation (hypoalbuminemia, hypergammaglobinemia), anti-smooth muscle, MOG antibody, elevated interleukin 2 receptor, elevated ESR, elevated CRP.   Normal/Negative - antiMPO/PR3, RF, anti-Smith, anti-SSB, anti-Scl70, anti-centromere, C3/C4, anti-CCP, anti-beta 2 glycoprotein 1 Ab, anti-cardiolipin Ab, urine studies, anti-ds-DNA, serum immunofixation, anti-mitochondrial aby, DRVVT, cryoglobulin, Hex lupus anticoagulant Negative NMO in CSF, TB   Pathology: Lip biopsy showed mild focal periductal chronic inflammation with focus score<1 (focus score 0.44).    INTERVAL HISTORY:  He he has noticed improvement after he was discharged.  He is able to walk at home without problem but he still uses walker whenever he goes out.  He denies any new neurologic symptoms. He is currently on prednisone 30 mg daily. He monitors his blood pressure every day and taking beta-blocker for it.  Beta-blocker is managed by primary doctor. His dry eyes and dry mouth do not really bother him.  He has been drinking a lot of fluid for the dry mouth.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test abnormal, Lacunar infarction, Myalgia, Mycobacterium tuberculosis complex test negative, Neurological symptom
Clinical narrative: received pfizer covid vaccines 3/29/2021 and 4/19/2021  as of 10 Dec 2021 Admission summary in 10/ 2021- This previously healthy young man with a history of sensorineural hearing loss approximately 10 years ago first developed some arthralgia following coronavirus 19 vaccination in April 2021 however he and his father report that the symptoms resolved and he returned to normal health before starting to feel poor again in the summer 2021.  He has developed intermittent myalgia and arthralgia and has been experiencing fevers.  He did develop fatigue and has been coughing for weeks.  He was admitted on 10/15 with left hemiparesis and found to have a subacute right lacunar infarct of unstated location and narrowing of bilateral external carotid arteries on CT. On 10/17, he developed right hemiparesis and acute dysphagia and found to have a right lateral medullar infarct. He was transferred another medical facility on 10/17. Rheumatology was consulted for evaluation of a rheumatologic process contributing to presentation in setting of reported ANA positive serology.    He does have unexplained fevers, inflammatory "arthritis", dry eyes (positive Schirmer's test on R eye, negative on L eye), dry mouth, neurologic symptoms (stroke), cytopenias, hypergammaglobulinemia, elevated Immunoglobulin level, positive ANA, weakly positive anti-SSA which could be explained by Sjogren's symptoms. People with seronegative (weakly positive in his case) Sjogren's tend to have neurological manifestations.    Received IV cyclophosphamide 500 mg/m2 (900 mg) (first dose on 11/6/2021), IV methylprednislone 500 mg bid x 6 doses. Tapered to equivalent of prednisone 1 mg/kg, Plaquenil 300 mg daily (started on 11/5/21)    Laboratory studies Abnormal - anti-SSA (2.5), ANA 1:640 homogeneous, SPEP consistent with chronic inflammation (hypoalbuminemia, hypergammaglobinemia), anti-smooth muscle, MOG antibody, elevated interleukin 2 receptor, elevated ESR, elevated CRP.   Normal/Negative - antiMPO/PR3, RF, anti-Smith, anti-SSB, anti-Scl70, anti-centromere, C3/C4, anti-CCP, anti-beta 2 glycoprotein 1 Ab, anti-cardiolipin Ab, urine studies, anti-ds-DNA, serum immunofixation, anti-mitochondrial aby, DRVVT, cryoglobulin, Hex lupus anticoagulant Negative NMO in CSF, TB   Pathology: Lip biopsy showed mild focal periductal chronic inflammation with focus score<1 (focus score 0.44).    INTERVAL HISTORY:  He he has noticed improvement after he was discharged.  He is able to walk at home without problem but he still uses walker whenever he goes out.  He denies any new neurologic symptoms. He is currently on prednisone 30 mg daily. He monitors his blood pressure every day and taking beta-blocker for it.  Beta-blocker is managed by primary doctor. His dry eyes and dry mouth do not really bother him.  He has been drinking a lot of fluid for the dry mouth.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Pathology test, Pyrexia, Red blood cell sedimentation rate increased, Rheumatoid factor negative, Russell's viper venom time normal
Clinical narrative: received pfizer covid vaccines 3/29/2021 and 4/19/2021  as of 10 Dec 2021 Admission summary in 10/ 2021- This previously healthy young man with a history of sensorineural hearing loss approximately 10 years ago first developed some arthralgia following coronavirus 19 vaccination in April 2021 however he and his father report that the symptoms resolved and he returned to normal health before starting to feel poor again in the summer 2021.  He has developed intermittent myalgia and arthralgia and has been experiencing fevers.  He did develop fatigue and has been coughing for weeks.  He was admitted on 10/15 with left hemiparesis and found to have a subacute right lacunar infarct of unstated location and narrowing of bilateral external carotid arteries on CT. On 10/17, he developed right hemiparesis and acute dysphagia and found to have a right lateral medullar infarct. He was transferred another medical facility on 10/17. Rheumatology was consulted for evaluation of a rheumatologic process contributing to presentation in setting of reported ANA positive serology.    He does have unexplained fevers, inflammatory "arthritis", dry eyes (positive Schirmer's test on R eye, negative on L eye), dry mouth, neurologic symptoms (stroke), cytopenias, hypergammaglobulinemia, elevated Immunoglobulin level, positive ANA, weakly positive anti-SSA which could be explained by Sjogren's symptoms. People with seronegative (weakly positive in his case) Sjogren's tend to have neurological manifestations.    Received IV cyclophosphamide 500 mg/m2 (900 mg) (first dose on 11/6/2021), IV methylprednislone 500 mg bid x 6 doses. Tapered to equivalent of prednisone 1 mg/kg, Plaquenil 300 mg daily (started on 11/5/21)    Laboratory studies Abnormal - anti-SSA (2.5), ANA 1:640 homogeneous, SPEP consistent with chronic inflammation (hypoalbuminemia, hypergammaglobinemia), anti-smooth muscle, MOG antibody, elevated interleukin 2 receptor, elevated ESR, elevated CRP.   Normal/Negative - antiMPO/PR3, RF, anti-Smith, anti-SSB, anti-Scl70, anti-centromere, C3/C4, anti-CCP, anti-beta 2 glycoprotein 1 Ab, anti-cardiolipin Ab, urine studies, anti-ds-DNA, serum immunofixation, anti-mitochondrial aby, DRVVT, cryoglobulin, Hex lupus anticoagulant Negative NMO in CSF, TB   Pathology: Lip biopsy showed mild focal periductal chronic inflammation with focus score<1 (focus score 0.44).    INTERVAL HISTORY:  He he has noticed improvement after he was discharged.  He is able to walk at home without problem but he still uses walker whenever he goes out.  He denies any new neurologic symptoms. He is currently on prednisone 30 mg daily. He monitors his blood pressure every day and taking beta-blocker for it.  Beta-blocker is managed by primary doctor. His dry eyes and dry mouth do not really bother him.  He has been drinking a lot of fluid for the dry mouth.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Schirmer's test abnormal, Sjogren's syndrome, Smooth muscle antibody, Urine analysis normal, Walking aid user
Clinical narrative: received pfizer covid vaccines 3/29/2021 and 4/19/2021  as of 10 Dec 2021 Admission summary in 10/ 2021- This previously healthy young man with a history of sensorineural hearing loss approximately 10 years ago first developed some arthralgia following coronavirus 19 vaccination in April 2021 however he and his father report that the symptoms resolved and he returned to normal health before starting to feel poor again in the summer 2021.  He has developed intermittent myalgia and arthralgia and has been experiencing fevers.  He did develop fatigue and has been coughing for weeks.  He was admitted on 10/15 with left hemiparesis and found to have a subacute right lacunar infarct of unstated location and narrowing of bilateral external carotid arteries on CT. On 10/17, he developed right hemiparesis and acute dysphagia and found to have a right lateral medullar infarct. He was transferred another medical facility on 10/17. Rheumatology was consulted for evaluation of a rheumatologic process contributing to presentation in setting of reported ANA positive serology.    He does have unexplained fevers, inflammatory "arthritis", dry eyes (positive Schirmer's test on R eye, negative on L eye), dry mouth, neurologic symptoms (stroke), cytopenias, hypergammaglobulinemia, elevated Immunoglobulin level, positive ANA, weakly positive anti-SSA which could be explained by Sjogren's symptoms. People with seronegative (weakly positive in his case) Sjogren's tend to have neurological manifestations.    Received IV cyclophosphamide 500 mg/m2 (900 mg) (first dose on 11/6/2021), IV methylprednislone 500 mg bid x 6 doses. Tapered to equivalent of prednisone 1 mg/kg, Plaquenil 300 mg daily (started on 11/5/21)    Laboratory studies Abnormal - anti-SSA (2.5), ANA 1:640 homogeneous, SPEP consistent with chronic inflammation (hypoalbuminemia, hypergammaglobinemia), anti-smooth muscle, MOG antibody, elevated interleukin 2 receptor, elevated ESR, elevated CRP.   Normal/Negative - antiMPO/PR3, RF, anti-Smith, anti-SSB, anti-Scl70, anti-centromere, C3/C4, anti-CCP, anti-beta 2 glycoprotein 1 Ab, anti-cardiolipin Ab, urine studies, anti-ds-DNA, serum immunofixation, anti-mitochondrial aby, DRVVT, cryoglobulin, Hex lupus anticoagulant Negative NMO in CSF, TB   Pathology: Lip biopsy showed mild focal periductal chronic inflammation with focus score<1 (focus score 0.44).    INTERVAL HISTORY:  He he has noticed improvement after he was discharged.  He is able to walk at home without problem but he still uses walker whenever he goes out.  He denies any new neurologic symptoms. He is currently on prednisone 30 mg daily. He monitors his blood pressure every day and taking beta-blocker for it.  Beta-blocker is managed by primary doctor. His dry eyes and dry mouth do not really bother him.  He has been drinking a lot of fluid for the dry mouth.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Interchange of vaccine products
Clinical narrative: Patient came to the local Health Center for his "initial" dose of COVID.  When he came in, he told the Customer Access Representative that this was his 1st COVID shot.  He told the me that he was here for his initial Moderna shot.  Moderna COVID-19 0.5 ml given IM to right deltoid, without difficulty.  After documenting the vaccine, I noticed in the database that patient received a J&J vaccine on 7/20/2021 at a local Pharmacy.  Lot # 203AZIA.  This Moderna COVID-19 was actually a Booster to the J&J, but was given at a higher dose that the normal Booster dosage. I called, today, to check on the patient, but he was out of his home, in the woods, with his in-laws.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Incorrect Dose, Received Pediatric dose as 2nd dose.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Headache, Incorrect dose administered, Skin warm
Clinical narrative: 8 year old patient was administered a covid 19 vaccine for patients 12 years and older.  Patients mother was contacted by the provider and support staff the day this was discovered. Patients mother reports patient has experienced headache and felt warm. Mother denies fever. Patients mother has office contact info in the case of any worsening symptoms.
Age: 12.0
Sex: M
Vaccine: FLU4
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient presented in the pharmacy to get COVID19 Pfizer shot but instead the patient was given flu vaccine.  No adverse event was stated by the parent as of 12/7/21 as initial screening  Will continue to follow up with the family
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: patient came in to get 2nd Pfizer pediatric vaccine and received adult vaccine
Age: 34.0
Sex: F
Vaccine: COVID19, FLUC4, COVID19, FLUC4
Symptoms: Injection site bruising, Injection site pain, Injection site pruritus
Clinical narrative: pt had arm pain, bruise, itching at site of injection. took ibuprofen to help with pain
Age: 34.0
Sex: F
Vaccine: COVID19, FLUC4, COVID19, FLUC4
Symptoms: Injection site pruritus
Clinical narrative: pt had arm pain, bruise, itching at site of injection. took ibuprofen to help with pain
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema peripheral, Tenderness, Ultrasound scan normal
Clinical narrative: On Aug. 16th, 2021, two days after 3rd vaccine. I noticed tenderness under my arm and noticed that it was very swollen up to about a tennis ball in size. Did not ache otherwise. By Friday, which I was able to get an appointment, the size was a third of the size, and after a week it was already gone, and symptoms subsided. No prescription given and no tenderness.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: 1640 Post-vaccination while participant was in monitoring area, RN noticed participant?s consent was for a second Moderna shot (0.5 ml). A Moderna booster shot was administered (0.25 ml). team lead RN and RN made aware.  1643 1645 Dr. made aware. Advised to inform patient to obtain Moderna booster in 6 months.   1647 The patient, made aware that a Moderna booster dose of 0.25ml was administered instead of Moderna second dose of 0.5 ml. Per Dr. was educated on getting the Moderna booster in 6 months. verbalized understanding.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Alanine aminotransferase, Asthenia, C-reactive protein, Chest X-ray, Differential white blood cell count
Clinical narrative: Weakness, fatigue, body aches, neck pain, daily fever beginning 48 hours after vaccine. Daily fever (triggers body aches) starting each morning with regular temperature increasing to 101.5 (max) every day around 4pm. Cross reactive antibody of epstein barr virus (mono). Positive EBV IVCA Igm 3 weeks and 2 days post vaccine.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Epstein-Barr virus antibody positive, Epstein-Barr virus test positive, Fatigue, Full blood count, Infectious mononucleosis
Clinical narrative: Weakness, fatigue, body aches, neck pain, daily fever beginning 48 hours after vaccine. Daily fever (triggers body aches) starting each morning with regular temperature increasing to 101.5 (max) every day around 4pm. Cross reactive antibody of epstein barr virus (mono). Positive EBV IVCA Igm 3 weeks and 2 days post vaccine.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain, Pyrexia, Red blood cell sedimentation rate, Urine analysis
Clinical narrative: Weakness, fatigue, body aches, neck pain, daily fever beginning 48 hours after vaccine. Daily fever (triggers body aches) starting each morning with regular temperature increasing to 101.5 (max) every day around 4pm. Cross reactive antibody of epstein barr virus (mono). Positive EBV IVCA Igm 3 weeks and 2 days post vaccine.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Viral load
Clinical narrative: Weakness, fatigue, body aches, neck pain, daily fever beginning 48 hours after vaccine. Daily fever (triggers body aches) starting each morning with regular temperature increasing to 101.5 (max) every day around 4pm. Cross reactive antibody of epstein barr virus (mono). Positive EBV IVCA Igm 3 weeks and 2 days post vaccine.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Headache, Insomnia, Myalgia
Clinical narrative: Pounding heart in my chest for 3-4 hours at bedtime (11:00pm) before I took a gabapentin to finally fall asleep at 2:45am. Seemed like my heart rate was very, very rapid. I could not settle my heart rate down at all. However I did take my own heart rate/pulse & it was only in the upper 60s bpm, so I did not go to the ER. But it still felt like my heart was working twice as hard as normal. I woke up feeling very tired, still with a very sore right arm muscle, a bad headache, as well as dizziness. But my heart rate was not elevated in the morning.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations
Clinical narrative: Pounding heart in my chest for 3-4 hours at bedtime (11:00pm) before I took a gabapentin to finally fall asleep at 2:45am. Seemed like my heart rate was very, very rapid. I could not settle my heart rate down at all. However I did take my own heart rate/pulse & it was only in the upper 60s bpm, so I did not go to the ER. But it still felt like my heart was working twice as hard as normal. I woke up feeling very tired, still with a very sore right arm muscle, a bad headache, as well as dizziness. But my heart rate was not elevated in the morning.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: TESTED POSITIVE FOR COVID ON 12/3/2021 PASSED AWAY 12/9/2021
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given 0.5ml iI of Moderna as a booster dose.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary normal, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Date of Admission: 11/10/2021   Date of Death:11/21/2021   Reason for Hospital Admission (Admitting Diagnosis): Covid pneumonia, acute hypoxic respiratory failure 89 Y male with purported dementia (per family, not clear if formally diagnosed), hypertension, hyperlipidemia, glaucoma, had recent covid booster on 11/5 who presented to ED on 11/10 with fatigue, shortness of breath, cough, anorexia.  Found to have covid pneumonia with acute hypoxic respiratory failure.  CXR with multifocal pneumonia.     Covid pneumonia/acute hypoxic respiratory failure:  Symptom onset 11/5, covid positive 11/10.  Pt received 5 day course of redemsivir (11/11-11/15/21), dose of tocilizumab (11/13/21), and high dose steroids.  Otherwise CTA of chest on 11/13 was negative for PE.  Despite the aforementioned treatments, pt continued to deteriorate with escalating oxygen requirements up to 60L and 100% high flow oxygen.  Family decided to forego ICU care and mechanical intubation.  After further discussions with family (grandson served as family spokesperson), they made difficult decision for comfort care on 11/19/21.  High flow oxygen removed, placed on morphine drip, and limited family members were allowed to visit.  Patient subsequently expired at 14:46 on 11/21/21.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Death, Decreased appetite, Dyspnoea, Fatigue
Clinical narrative: Date of Admission: 11/10/2021   Date of Death:11/21/2021   Reason for Hospital Admission (Admitting Diagnosis): Covid pneumonia, acute hypoxic respiratory failure 89 Y male with purported dementia (per family, not clear if formally diagnosed), hypertension, hyperlipidemia, glaucoma, had recent covid booster on 11/5 who presented to ED on 11/10 with fatigue, shortness of breath, cough, anorexia.  Found to have covid pneumonia with acute hypoxic respiratory failure.  CXR with multifocal pneumonia.     Covid pneumonia/acute hypoxic respiratory failure:  Symptom onset 11/5, covid positive 11/10.  Pt received 5 day course of redemsivir (11/11-11/15/21), dose of tocilizumab (11/13/21), and high dose steroids.  Otherwise CTA of chest on 11/13 was negative for PE.  Despite the aforementioned treatments, pt continued to deteriorate with escalating oxygen requirements up to 60L and 100% high flow oxygen.  Family decided to forego ICU care and mechanical intubation.  After further discussions with family (grandson served as family spokesperson), they made difficult decision for comfort care on 11/19/21.  High flow oxygen removed, placed on morphine drip, and limited family members were allowed to visit.  Patient subsequently expired at 14:46 on 11/21/21.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: General physical health deterioration, SARS-CoV-2 test positive
Clinical narrative: Date of Admission: 11/10/2021   Date of Death:11/21/2021   Reason for Hospital Admission (Admitting Diagnosis): Covid pneumonia, acute hypoxic respiratory failure 89 Y male with purported dementia (per family, not clear if formally diagnosed), hypertension, hyperlipidemia, glaucoma, had recent covid booster on 11/5 who presented to ED on 11/10 with fatigue, shortness of breath, cough, anorexia.  Found to have covid pneumonia with acute hypoxic respiratory failure.  CXR with multifocal pneumonia.     Covid pneumonia/acute hypoxic respiratory failure:  Symptom onset 11/5, covid positive 11/10.  Pt received 5 day course of redemsivir (11/11-11/15/21), dose of tocilizumab (11/13/21), and high dose steroids.  Otherwise CTA of chest on 11/13 was negative for PE.  Despite the aforementioned treatments, pt continued to deteriorate with escalating oxygen requirements up to 60L and 100% high flow oxygen.  Family decided to forego ICU care and mechanical intubation.  After further discussions with family (grandson served as family spokesperson), they made difficult decision for comfort care on 11/19/21.  High flow oxygen removed, placed on morphine drip, and limited family members were allowed to visit.  Patient subsequently expired at 14:46 on 11/21/21.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure decreased, Blood pressure increased, Electrocardiogram normal, Enzyme level increased, Myocardial infarction
Clinical narrative: The evening I received the vaccine my blood pressure dropped way down.   The next day it started climbing back to normal.  The problem was it kept climbing for the next 3 weeks.  When I checked into the hospital my blood pressure was 220/105 and enzyme levels were elevated but EKG showed no blockage.  The doctor said I was having a heart attack and was transported to the hospital .
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 15 year old given a booster dose which is currently approved for patients 16 years and older
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Nausea, Pain, Pain in extremity
Clinical narrative: About 1 1/2 hours after the vaccine, I began to have bad waves of nausea. In three hours I was vomiting. Took Zofran for that.  Sore arm, swelling, chills, bad body aches, low grade fever? Next day, dizzy and nauseated (little bit vomiting).  Third day, I am feeling fine. Would do it again!!! Don't want the virus!
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Swelling, Vomiting
Clinical narrative: About 1 1/2 hours after the vaccine, I began to have bad waves of nausea. In three hours I was vomiting. Took Zofran for that.  Sore arm, swelling, chills, bad body aches, low grade fever? Next day, dizzy and nauseated (little bit vomiting).  Third day, I am feeling fine. Would do it again!!! Don't want the virus!
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, Condition aggravated, Deep vein thrombosis, Ex-tobacco user
Clinical narrative: A/P: 29 yo male with PMH of recurrent PE/DVT, HTN and anxiety/depression who is transferred from the medical facility for management of PE/DVT.  He has a reported history of protein C deficiency diagnosed at the medical facility.   1. Recurrent PE/DVT; acute PE and LLE DVT -first VTE 2017- RLE, placed on Xarelto -had covid vaccines at outside facility in mar and apr of 2021 -2nd and 3rd clots, both legs, after missing a few doses -4th clot in LLE march/april 2021- changed to coumadin. INRs were hard to control -5th clot LLE September 2021- back to Xarelto -? Protein C def -currently quitting smoking- uses patch and gum  -adopted, doesn't know FH -reports might have missed 3-4 doses in the past month -OSH CTA chest: multiple b/l lower lobe PE, and infarcts -11/1/21 BLE U/S:  Acute, occlusive deep venous thrombosis in the left iliac vein extending into the popliteal vein and tibioperoneal trunk. There also appears to be acute thrombus in one of the left peroneal veins. 2.  Near occlusive thrombus in the lower IVC, without definite mid or upper IVC thrombus.  No evidence of deep venous thrombosis in the right lower extremity. There is decreased pulsatility within the right lower extremity consistent with the lower IVC clot.  -11/2 IR tPA + heparin drip stopped 11/4 w/ iliac vein stent    -By history it seems he has recurrent clotting after missing only a dose or two of anticoagulation, although he was also not taking the Xarelto consistently with food. We recommended Lovenox 1mg/kg BID after thrombolysis completed and then ok to discharge on Lovenox 1.5 mg/kg once daily but he is concerned re: compliance.  Therefore will avoid shots, add ASA to Xarelto as that may be the best change as he is young and active and has trouble remembering to take his pills, highly recommend compliance every single day and to get a pillbox and to make sure that he has taken his daily doses of Xarelto and aspirin, can take with food
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Iliac vein occlusion, International normalised ratio abnormal, Pelvic venous thrombosis, Peripheral pulse decreased, Pulmonary embolism
Clinical narrative: A/P: 29 yo male with PMH of recurrent PE/DVT, HTN and anxiety/depression who is transferred from the medical facility for management of PE/DVT.  He has a reported history of protein C deficiency diagnosed at the medical facility.   1. Recurrent PE/DVT; acute PE and LLE DVT -first VTE 2017- RLE, placed on Xarelto -had covid vaccines at outside facility in mar and apr of 2021 -2nd and 3rd clots, both legs, after missing a few doses -4th clot in LLE march/april 2021- changed to coumadin. INRs were hard to control -5th clot LLE September 2021- back to Xarelto -? Protein C def -currently quitting smoking- uses patch and gum  -adopted, doesn't know FH -reports might have missed 3-4 doses in the past month -OSH CTA chest: multiple b/l lower lobe PE, and infarcts -11/1/21 BLE U/S:  Acute, occlusive deep venous thrombosis in the left iliac vein extending into the popliteal vein and tibioperoneal trunk. There also appears to be acute thrombus in one of the left peroneal veins. 2.  Near occlusive thrombus in the lower IVC, without definite mid or upper IVC thrombus.  No evidence of deep venous thrombosis in the right lower extremity. There is decreased pulsatility within the right lower extremity consistent with the lower IVC clot.  -11/2 IR tPA + heparin drip stopped 11/4 w/ iliac vein stent    -By history it seems he has recurrent clotting after missing only a dose or two of anticoagulation, although he was also not taking the Xarelto consistently with food. We recommended Lovenox 1mg/kg BID after thrombolysis completed and then ok to discharge on Lovenox 1.5 mg/kg once daily but he is concerned re: compliance.  Therefore will avoid shots, add ASA to Xarelto as that may be the best change as he is young and active and has trouble remembering to take his pills, highly recommend compliance every single day and to get a pillbox and to make sure that he has taken his daily doses of Xarelto and aspirin, can take with food
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary infarction, Thrombosis, Treatment noncompliance, Ultrasound Doppler abnormal, Vena cava thrombosis
Clinical narrative: A/P: 29 yo male with PMH of recurrent PE/DVT, HTN and anxiety/depression who is transferred from the medical facility for management of PE/DVT.  He has a reported history of protein C deficiency diagnosed at the medical facility.   1. Recurrent PE/DVT; acute PE and LLE DVT -first VTE 2017- RLE, placed on Xarelto -had covid vaccines at outside facility in mar and apr of 2021 -2nd and 3rd clots, both legs, after missing a few doses -4th clot in LLE march/april 2021- changed to coumadin. INRs were hard to control -5th clot LLE September 2021- back to Xarelto -? Protein C def -currently quitting smoking- uses patch and gum  -adopted, doesn't know FH -reports might have missed 3-4 doses in the past month -OSH CTA chest: multiple b/l lower lobe PE, and infarcts -11/1/21 BLE U/S:  Acute, occlusive deep venous thrombosis in the left iliac vein extending into the popliteal vein and tibioperoneal trunk. There also appears to be acute thrombus in one of the left peroneal veins. 2.  Near occlusive thrombus in the lower IVC, without definite mid or upper IVC thrombus.  No evidence of deep venous thrombosis in the right lower extremity. There is decreased pulsatility within the right lower extremity consistent with the lower IVC clot.  -11/2 IR tPA + heparin drip stopped 11/4 w/ iliac vein stent    -By history it seems he has recurrent clotting after missing only a dose or two of anticoagulation, although he was also not taking the Xarelto consistently with food. We recommended Lovenox 1mg/kg BID after thrombolysis completed and then ok to discharge on Lovenox 1.5 mg/kg once daily but he is concerned re: compliance.  Therefore will avoid shots, add ASA to Xarelto as that may be the best change as he is young and active and has trouble remembering to take his pills, highly recommend compliance every single day and to get a pillbox and to make sure that he has taken his daily doses of Xarelto and aspirin, can take with food
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Venous occlusion, Venous stent insertion
Clinical narrative: A/P: 29 yo male with PMH of recurrent PE/DVT, HTN and anxiety/depression who is transferred from the medical facility for management of PE/DVT.  He has a reported history of protein C deficiency diagnosed at the medical facility.   1. Recurrent PE/DVT; acute PE and LLE DVT -first VTE 2017- RLE, placed on Xarelto -had covid vaccines at outside facility in mar and apr of 2021 -2nd and 3rd clots, both legs, after missing a few doses -4th clot in LLE march/april 2021- changed to coumadin. INRs were hard to control -5th clot LLE September 2021- back to Xarelto -? Protein C def -currently quitting smoking- uses patch and gum  -adopted, doesn't know FH -reports might have missed 3-4 doses in the past month -OSH CTA chest: multiple b/l lower lobe PE, and infarcts -11/1/21 BLE U/S:  Acute, occlusive deep venous thrombosis in the left iliac vein extending into the popliteal vein and tibioperoneal trunk. There also appears to be acute thrombus in one of the left peroneal veins. 2.  Near occlusive thrombus in the lower IVC, without definite mid or upper IVC thrombus.  No evidence of deep venous thrombosis in the right lower extremity. There is decreased pulsatility within the right lower extremity consistent with the lower IVC clot.  -11/2 IR tPA + heparin drip stopped 11/4 w/ iliac vein stent    -By history it seems he has recurrent clotting after missing only a dose or two of anticoagulation, although he was also not taking the Xarelto consistently with food. We recommended Lovenox 1mg/kg BID after thrombolysis completed and then ok to discharge on Lovenox 1.5 mg/kg once daily but he is concerned re: compliance.  Therefore will avoid shots, add ASA to Xarelto as that may be the best change as he is young and active and has trouble remembering to take his pills, highly recommend compliance every single day and to get a pillbox and to make sure that he has taken his daily doses of Xarelto and aspirin, can take with food
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: No adverse events pt was given a PEDS dose of Pfizer for his second dose his mother was notified and aware he will need to come back for the other part of the dose for his series to be completed.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Blood glucose decreased, Decreased appetite, Fatigue, Lymphadenopathy
Clinical narrative: Patient reporting pain, swelling in right arm pit. Patient also reports feeling really tired , no appetite and blood sugar dropping really low.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given dose of 0.5 ml Im of Moderna Vaccine as booster dose.
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Oral discomfort
Clinical narrative: Patient called pharmacy reporting mouth felt different the night after receiving Shingrix.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: I got hives from booster, Moderna, booster, both prior shots were Moderna, booster I'm allergic to. Hives for an entire month, went to ER twice
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Incorrect dose administered, Injection site pain, Pyrexia
Clinical narrative: Patient was given a full dose of the Pfizer adult vaccine for her second dose instead of the Pfizer PED vaccine. One hour after the dose, no symptoms were observed, however, the next morning when we touched based with the parents again, the father reported that she had a temperature around 100F, soreness in the left arm where the vaccine was administered, and fatigue, which we informed the parents to look out for after speaking to representatives from CDC and Pfizer regarding the incident. Recommended the parents to keep an eye on her and provide children's Tylenol to help with the fever; also to keep her hydrated during the day.  No other discomfort or symptoms reported by parents.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Gait inability, Grip strength decreased, Guillain-Barre syndrome, Joint range of motion decreased, Lumbar puncture abnormal
Clinical narrative: Gillian Barre - First noticed as weakness in both hands/fingers. Then could not straighten fingers. Traveled to legs and feet. Could not walk. Spent 1 week in hospital. at wich time I was given medication through an IV. 5 vilas  given 1 vial a day. Transfered to in patient rehad facility for 1 week. Finally had months of out patient rehab (ot and pt treatments) As of today, 12/10/2021 only about 80% recovered. Must use a cane when walking. Can not walk far (get tired very easily) 50% recovers in hands/fingers. Can not still straighten fingers and very little griping strength
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Walking aid user
Clinical narrative: Gillian Barre - First noticed as weakness in both hands/fingers. Then could not straighten fingers. Traveled to legs and feet. Could not walk. Spent 1 week in hospital. at wich time I was given medication through an IV. 5 vilas  given 1 vial a day. Transfered to in patient rehad facility for 1 week. Finally had months of out patient rehab (ot and pt treatments) As of today, 12/10/2021 only about 80% recovered. Must use a cane when walking. Can not walk far (get tired very easily) 50% recovers in hands/fingers. Can not still straighten fingers and very little griping strength
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Client presented to clinic and requested to receive his second dose of the COVID vaccine. The client had previously received his first dose of Pfizer on 10/26/21. It was explained that Pfizer was not available at today?s vaccine clinic and programmatic staff tried to assist the individual in exploring options to receive his second dose. The client verbalized that it was unlikely that he would follow through in exploring any of the available options since he was unable to leave the facility and therefore was unlikely to get his second dose of the COVID vaccine. Staff explained the potential risks and benefits of mixing vaccines and the client opted to proceed with getting Moderna as his second dose.  Client waited for 15 minute monitoring period and no adverse reactions noted.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Feeling abnormal, Rash, Swelling face
Clinical narrative: I was taking Benadryl, Zyrtec and Claritin to help with the rash obtained from the first dose. after the second dose, the next night I woke up with a rash all over my body and facial swelling. Brain Fog for 2 months after. I havecontinued breaking out in a rash if I don't take benadryl Zyrtec and Claritan daily. I also have shortness of breath and a cough related to the Covid 19 vaccine.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Anticoagulant therapy, Bladder trabeculation, Blood creatinine normal, Blood loss anaemia
Clinical narrative: note from 11/23/21 had pfizer covid vaccines 2/24/21, 3/19/21, and 10/5/2021, i do not have lot number for the 10/5/2021 dose  A/P: Pt is a 70 y.o. male with PMH of HTN, gerd, BPH who is transferred from a HCF with massive PE s/p ROSC and tPA. Placed on eliquis and developed right anterior chest and arm hematoma and need IVC filter placement. Now w/ e/o HIT, suspect classic HIT, w/in 5-10 days of heparin exposure, plt count nadir at 130 (>50% decline from 283) w/ h/o thrombosis and HIT Ab >2 OD (2.765) 4Ts of at least 5 or intermed, and w/ elev OD c/w and diagnostic for HIT. Suspect covid vaccine booster on 5 October 2021 could have been a risk factor for his initial presentation with PE and DVT however as the HIT is greater than 30 days post Covid vaccine and not present at initial presentation, this is not consistent with VITT at this point in time.   1. Massive PE s/p ROSC; acute LLE DVT and HIT -HCF CTA of chest which revealed acute bilateral PE with large clot burden and evidence of pulmonary hypertension and right heart strain -Echo from 11/15/2021 revealed EF of 70%, moderate diastolic dysfunction, right ventricular systolic pressure of 34.6 mmhg -Became pulseless while going to the restroom, was given tPA, intubated, required levophed  -Received heparin and then eliquis @ HCF- last dose 11/14/21 2/2 bleeding -11/16/21 BLE U/S: 1. Acute-appearing, occlusive and nonocclusive thrombus in the left low femoral vein, as well as occlusive thrombus in the left popliteal vein. No right lower extremity DVT. -AC back on, apix 2.5 bid, ok to go to 5 mg bid -rec avoiding further covid shots due to poss contribution to clot -avoid heparin, it is an allergy now, w/ dx of HIT -plt already improving, currently on DOAC   2. Acute blood loss anemia -2/2 right anterior chest and arm hematoma while on Eliquis  -Patient had right upper extremity arterial Doppler which did not reveal significant stenosis.  He also had right upper extremity venous Doppler which revealed large hematoma involving the anterior chest and extending down the medial aspect of the right arm. -Hgb stable/improved -back on AC, ok to go to full dose   3. AKI -Cr 0.9 @ HCF admit, currently 0.82 -Renal ultrasound at HCF revealed renal cortical atrophy bilaterally.  Enlarged prostate with palpable trabeculation.  Questionable nonobstructing left renal stone.   Recommendations: -resume eliquis 5 mg po bid  -avoid heparin products -f/u w/ Dr at HCF next wk
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Chest wall haematoma, Computerised tomogram thorax abnormal, Deep vein thrombosis, Diastolic dysfunction, Echocardiogram abnormal
Clinical narrative: note from 11/23/21 had pfizer covid vaccines 2/24/21, 3/19/21, and 10/5/2021, i do not have lot number for the 10/5/2021 dose  A/P: Pt is a 70 y.o. male with PMH of HTN, gerd, BPH who is transferred from a HCF with massive PE s/p ROSC and tPA. Placed on eliquis and developed right anterior chest and arm hematoma and need IVC filter placement. Now w/ e/o HIT, suspect classic HIT, w/in 5-10 days of heparin exposure, plt count nadir at 130 (>50% decline from 283) w/ h/o thrombosis and HIT Ab >2 OD (2.765) 4Ts of at least 5 or intermed, and w/ elev OD c/w and diagnostic for HIT. Suspect covid vaccine booster on 5 October 2021 could have been a risk factor for his initial presentation with PE and DVT however as the HIT is greater than 30 days post Covid vaccine and not present at initial presentation, this is not consistent with VITT at this point in time.   1. Massive PE s/p ROSC; acute LLE DVT and HIT -HCF CTA of chest which revealed acute bilateral PE with large clot burden and evidence of pulmonary hypertension and right heart strain -Echo from 11/15/2021 revealed EF of 70%, moderate diastolic dysfunction, right ventricular systolic pressure of 34.6 mmhg -Became pulseless while going to the restroom, was given tPA, intubated, required levophed  -Received heparin and then eliquis @ HCF- last dose 11/14/21 2/2 bleeding -11/16/21 BLE U/S: 1. Acute-appearing, occlusive and nonocclusive thrombus in the left low femoral vein, as well as occlusive thrombus in the left popliteal vein. No right lower extremity DVT. -AC back on, apix 2.5 bid, ok to go to 5 mg bid -rec avoiding further covid shots due to poss contribution to clot -avoid heparin, it is an allergy now, w/ dx of HIT -plt already improving, currently on DOAC   2. Acute blood loss anemia -2/2 right anterior chest and arm hematoma while on Eliquis  -Patient had right upper extremity arterial Doppler which did not reveal significant stenosis.  He also had right upper extremity venous Doppler which revealed large hematoma involving the anterior chest and extending down the medial aspect of the right arm. -Hgb stable/improved -back on AC, ok to go to full dose   3. AKI -Cr 0.9 @ HCF admit, currently 0.82 -Renal ultrasound at HCF revealed renal cortical atrophy bilaterally.  Enlarged prostate with palpable trabeculation.  Questionable nonobstructing left renal stone.   Recommendations: -resume eliquis 5 mg po bid  -avoid heparin products -f/u w/ Dr at HCF next wk